Elsa Ohlen

London

Reporter at Barron's

Articles

Pharma Worries Shift to Prices From Trade. Trump’s Next Plan Could Sink Stocks.

4 days ago | barrons.com | Elsa Ohlen

The biggest threat to pharmaceutical companies may not be tariffs after all. Potential lower prices risk not only bringing down revenue from medicines already on the market, but also hurting the long-term innovation that is crucial for the industry. The pharmaceutical sector is facing a trifecta of threats from Washington, Leerink Partners analyst David Risinger told Barron’s on Friday.
Bitcoin, XRP Soar. Cryptos Are So Back-Unless They’re Not.

5 days ago | finance.yahoo.com | Elsa Ohlen

While Bitcoin and other cryptos have seen impressive double digit gains this week there are risks to the rally.
How MicroStrategy, Coinbase, Other Crypto Stocks Are Trading After Bitcoin Hit $100,000

5 days ago | barrons.com | Elsa Ohlen

Crypto-related stocks have seen big upticks this week as Bitcoin gained momentum, pushing through the psychologically important level of $100,000 for the first time in months. The cryptocurrency held on to most of its gain early Friday—and crypto stocks mostly followed. The largest corporate holder of Bitcoin, MicroStrategy, rose another 3% to $426.79 in early trading following a 5.6% gain Thursday. Crypto exchange Robinhood was up 3.5% to $55.95 following an 8.2% gain Thursday.
How MicroStrategy, Coinbase, Other Crypto Stocks Are Trading After Bitcoin Hit $100,000

5 days ago | barrons.com | Elsa Ohlen

Crypto-related stocks have seen big upticks this week as Bitcoin gained momentum, pushing through the psychologically important level of $100,000 for the first time in months. The cryptocurrency held on to most of its gain early Friday—but not all crypto stocks followed. The largest corporate holder of Bitcoin, MicroStrategy, rose another 1.9% to $422.33 in premarket trading following a 5.6% gain Thursday. Crypto exchange Robinhood was up 1.2% to $54.71 following a 8.2% gain Thursday.
Nvidia Stock Stalls. Why a New AI Chip Won't Fix Its China Problems.

5 days ago | barrons.com | Adam Clark |Elsa Ohlen

Nvidia stock was wavering early Friday as the market was digesting news on trade deals and the potential for a new artificial-intelligence chip for the Chinese market. Shares, which are up 2.5% this week through Thursday’s close, edged 0.2% higher to $117.63 in premarket trading. Futures tracking the tech-heavy Nasdaq 100 were up 0.3%. Nvidia stock has risen 7.8% so far in May amid renewed optimism over trade and tariffs.
Bitcoin Price, XRP Soar. Here’s the Risk to the Crypto Rally.

5 days ago | barrons.com | Elsa Ohlen

Bitcoin price rallied after a week that reignited investors’ risk appetite, particularly for digital assets.
Bitcoin Price, XRP Rise as U.S. and China Set to Start Trade Talks

6 days ago | barrons.com | Elsa Ohlen

Bitcoin price rose early Wednesday as hopes of a de-escalation in trade tensions between the U.S. and China trade lifted cryptocurrencies. Bitcoin has climbed 3.6% to $97,014 over the last 24 hours, according to CoinDesk data. Ether rose 3.8%, XRP climbed 2.1% and Solana gained 3.3%. The benchmark S&P 500 was up 0.3% in morning trading. “We don’t want to decouple [with China], what we want is fair trade,” Treasury Secretary Scott Bessent said in an interview on Fox News late Tuesday.
MicroStrategy, Robinhood, and Coinbase Stocks Jump. Here’s Why.

6 days ago | barrons.com | Mackenzie Tatananni |Elsa Ohlen

Cryptocurrency-linked stocks rallied along with the price of Bitcoin on Thursday after President Donald Trump said the U.S. had reached a “breakthrough” trade deal with the U.K.Cryptocurrency exchanges Robinhood Markets and Coinbase Global followed the price of Bitcoin higher as the digital currency traded at $100,649, crossing $100,000 for the first time since February. Robinhood rose 8.6% and Coinbase gained 6.1%. Company-specific news also was giving Coinbase a lift.
Why This Shrinking Covid-19 Vaccine Stock Jumped 30%

6 days ago | barrons.com | Elsa Ohlen

Vaccine maker Novavax stock jumped double digits on Thursday after the company reported its quarterly sales had more than fivefold. Shares rose as much 30% at the opening bell, but later pared backs its gains. In midmorning trading the stock was up 17% at $6.93. First-quarter earnings were $2.93 a share on sales of $667 million. The numbers trounced Wall Street’s expectation of a loss of 42 cents a share on sales of $92 million, according to a small group of analysts surveyed by FactSet.
Why This Shrinking Covid-19 Vaccine Stock Jumped 30%

6 days ago | marketwatch.com | Elsa Ohlen

Shares rose as much 30% at the opening bell, but later pared backs its gains. In midmorning trading the stock was up 17% at $6.93. First-quarter earnings were $2.93 a share on sales of $667 million. The numbers trounced Wall Street’s expectation of a loss of 42 cents a share on sales of $92 million, according to a small group of analysts surveyed by FactSet.